Lack of evidence supporting a role for dopamine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Schmidt
C J
CJ
Bruckwick
E
E
Lovenberg
W
W
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D004298:Dopamine / Q000502:physiology*; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009474:Neurons / Q000187:drug effects; D011725:Pyridines / Q000633:toxicity*; D011954:Receptors, Dopamine / Q000187:drug effects*; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D019805:alpha-Methyltyrosine
D008781:Methyltyrosines; D011725:Pyridines; D011954:Receptors, Dopamine; D007980:Levodopa; D019805:alpha-Methyltyrosine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine